MX361804B - Vacunas genéticas contra el virus hendra y el virus nipah. - Google Patents
Vacunas genéticas contra el virus hendra y el virus nipah.Info
- Publication number
- MX361804B MX361804B MX2013013812A MX2013013812A MX361804B MX 361804 B MX361804 B MX 361804B MX 2013013812 A MX2013013812 A MX 2013013812A MX 2013013812 A MX2013013812 A MX 2013013812A MX 361804 B MX361804 B MX 361804B
- Authority
- MX
- Mexico
- Prior art keywords
- virus
- nipah
- vaccines against
- genetic vaccines
- hendra virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18211—Henipavirus, e.g. hendra virus
- C12N2760/18222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18211—Henipavirus, e.g. hendra virus
- C12N2760/18234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
Abstract
La presente invención proporciona vectores que contienen y expresan in vivo o in vitro uno o más polipéptidos o antígenos del virus Hendra que inducen una respuesta inmune en el animal o humano contra el virus Hendra y el virus Nipah, composiciones que comprenden los vectores y/o polipéptidos del virus 1-lendra, métodos de vacunación contra el virus Hendra y el virus Nipah, y equipos para el uso con tales métodos y composiciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161491037P | 2011-05-27 | 2011-05-27 | |
PCT/US2012/039026 WO2012166450A1 (en) | 2011-05-27 | 2012-05-23 | Genetic vaccines against hendra virus and nipah virus |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013013812A MX2013013812A (es) | 2014-05-28 |
MX361804B true MX361804B (es) | 2018-12-17 |
Family
ID=46208825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013013812A MX361804B (es) | 2011-05-27 | 2012-05-23 | Vacunas genéticas contra el virus hendra y el virus nipah. |
Country Status (8)
Country | Link |
---|---|
US (2) | US20120301479A1 (es) |
EP (1) | EP2714722B1 (es) |
AU (1) | AU2012262740B2 (es) |
CA (1) | CA2837582C (es) |
ES (1) | ES2764079T3 (es) |
MX (1) | MX361804B (es) |
NZ (1) | NZ618125A (es) |
WO (1) | WO2012166450A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210252134A1 (en) * | 2018-08-21 | 2021-08-19 | The Wistar Institute Of Anatomy And Biology | Vaccines against nipah virus, and methods of using same |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
EP0138854B1 (en) | 1983-03-08 | 1992-11-04 | Chiron Mimotopes Pty. Ltd. | Antigenically active amino acid sequences |
EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
KR100242671B1 (ko) | 1991-03-07 | 2000-03-02 | 고돈 에릭 | 유전학적으로 처리한 백신 균주 |
EP0826063A1 (en) | 1995-04-25 | 1998-03-04 | Vical Incorporated | Single-vial formulations of dna/lipid complexes |
US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
FR2751226B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
FR2751225B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
FR2751228B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Vaccin polynucleotidique bovin pour voie intradermique |
FR2751229B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
FR2751224B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs |
FR2751227B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives |
ES2241042T3 (es) | 1996-10-11 | 2005-10-16 | The Regents Of The University Of California | Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora. |
CN1261807A (zh) | 1997-06-30 | 2000-08-02 | 罗纳-布朗克罗莱尔股份有限公司 | 向横纹肌中转移核酸的改进方法和用于实施该方法的组合 |
FR2778858B1 (fr) | 1998-05-20 | 2000-06-16 | Oreal | Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique |
FR2801607B1 (fr) | 1999-11-26 | 2001-12-28 | Merial Sas | Pneumovirus du canard et vaccins correspondants |
US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
RU2354399C2 (ru) | 2003-07-24 | 2009-05-10 | Мериал Лимитед | Вакцинная композиция и способ индуцирования иммунологического ответа у животного |
JP2007505618A (ja) * | 2003-09-22 | 2007-03-15 | インスティティ・パスツール | ニパウイルスの検出方法及びヘニパウイルスに対する免疫保護を提供する方法 |
WO2006085979A2 (en) * | 2004-07-09 | 2006-08-17 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Soluble forms of hendra and nipah virus g glycoprotein |
RS51324B (sr) * | 2005-04-25 | 2010-12-31 | Merial Ltd. | Vakcine protiv nipah virusa |
WO2012158643A1 (en) * | 2011-05-13 | 2012-11-22 | Ah Usa 42 Llc | Hendra and nipah virus g glycoprotein immunogenic compositions |
-
2012
- 2012-05-23 US US13/478,165 patent/US20120301479A1/en not_active Abandoned
- 2012-05-23 AU AU2012262740A patent/AU2012262740B2/en active Active
- 2012-05-23 ES ES12725974T patent/ES2764079T3/es active Active
- 2012-05-23 NZ NZ618125A patent/NZ618125A/en unknown
- 2012-05-23 WO PCT/US2012/039026 patent/WO2012166450A1/en active Application Filing
- 2012-05-23 CA CA2837582A patent/CA2837582C/en active Active
- 2012-05-23 MX MX2013013812A patent/MX361804B/es active IP Right Grant
- 2012-05-23 EP EP12725974.5A patent/EP2714722B1/en active Active
-
2016
- 2016-08-10 US US15/233,013 patent/US10350287B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
NZ618125A (en) | 2016-03-31 |
MX2013013812A (es) | 2014-05-28 |
US20170087242A1 (en) | 2017-03-30 |
US10350287B2 (en) | 2019-07-16 |
CA2837582A1 (en) | 2012-12-06 |
ES2764079T3 (es) | 2020-06-02 |
AU2012262740B2 (en) | 2017-06-01 |
EP2714722B1 (en) | 2019-09-11 |
CA2837582C (en) | 2021-03-02 |
EP2714722A1 (en) | 2014-04-09 |
WO2012166450A1 (en) | 2012-12-06 |
US20120301479A1 (en) | 2012-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021001098A (es) | Anticuerpos de un solo dominio dirigidos contra antigenos intracelulares. | |
MX2022005955A (es) | Metodos y composiciones para terapia celular adoptiva. | |
WO2016070166A3 (en) | Messenger una molecules and uses thereof | |
EA201691631A1 (ru) | Иммунотерапия рака с применением комбинации местной и системной иммунной стимуляции | |
TW201613962A (en) | Fabs-in-tandem immunoglobulin and uses thereof | |
CY1120430T1 (el) | Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων | |
MX360415B (es) | Vectores poxvirales recombinantes que expresan proteinas tanto de rabia como de ox40, y vacunas hechas a partir de los mismos. | |
WO2013106834A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
PH12014502855A1 (en) | Attenuated streptococcus suis vaccines and methods of making and use thereof | |
TN2014000518A1 (en) | Reassortant btv and ahsv vaccines | |
MX2018005154A (es) | Anticuerpos de dominio unico dirigidos contra el virus de la inmunodeficiencia humana. | |
MX349657B (es) | Composiciones de vacuna de matriz de proteína que incluyen policationes. | |
MX2018013409A (es) | Métodos y dispositivos para la preparación de agentes de contraste de ultrasonido. | |
PH12014501795B1 (en) | Rotavirus subunit vaccines and methods of making and use thereof | |
CY1125328T1 (el) | Ανασυνδυασμενο εμβολιο ιου λευχαιμιας αιλουροειδων περιεχοντας βελτιστοποιημενο γονιδιο φακελου ιου λευχαιμιας αιλουροειδων | |
NZ730708A (en) | Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof | |
MX2011004219A (es) | Vacuna contra el virus de la peste equina africana. | |
MX348137B (es) | Vacuna de la leishmaniasis con el uso del inmunogeno salival de la mosca de la arena. | |
MY188100A (en) | Compositions and methods vectors for inducing an enhanced immune response using poxvirus vectors | |
EA201792512A1 (ru) | Составы для доставки антигенов респираторного синтициального вируса и норовируса в тонкий кишечник | |
MX361804B (es) | Vacunas genéticas contra el virus hendra y el virus nipah. | |
TN2010000500A1 (en) | Leishmania vaccine using sand fly salivary immunogen | |
MX2018013358A (es) | Vacunas para el virus del papiloma humano y metodos para su uso. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
PD | Change of proprietorship |
Owner name: MERIAL, INC. |